Table of Content

1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Market Definition
3.2. Key Drivers
3.2.1. Increasing Road Accidents And Surgical Procedures
3.2.2. Escalating Palliative Care For Patients Suffering Intensely
3.2.3. Usage Of Abuse Deterrent Formulations To Restrict The Opioid Abuse
3.2.4. Growing Occurrence Of Chronic Pain
3.3. Key Restraints
3.3.1. Misuse Of Opioids
3.3.2. Stringent Regulatory Framework

4. Key Analytics
4.1. Key Investment Insights
4.2. Porter’S Five Force Analysis
4.2.1. Buyer Power
4.2.2. Supplier Power
4.2.3. Substitution
4.2.4. New Entrants
4.2.5. Industry Rivalry
4.3. Opportunity Matrix
4.4. Vendor Landscape
4.5. Regulatory Framework
4.6. Technological Advancement

5. Market By Product
5.1. Buprenorphine
5.2. Fentanyl
5.3. Hydrocodone
5.4. Morphine
5.5. Oxycodone
5.6. Tramadol
5.7. Other Products

6. Market By Application
6.1. Pain Relief
6.1.1. Cancer Pain
6.1.2. Postoperative Pain Management
6.1.3. Low Back Pain
6.1.4. Orthopedic
6.1.5. Fibromyalgia
6.1.6. Neuropathic
6.2. Anesthesia
6.3. Cough Suppression
6.4. Diarrhea Suppression
6.5. Deaddiction

7. Geographical Analysis
7.1. Asia Pacific
7.1.1. China
7.1.2. Japan
7.1.3. India
7.1.4. South Korea
7.1.5. Indonesia
7.1.6. Thailand
7.1.7. Vietnam
7.1.8. Australia & New Zealand
7.1.9. Rest Of Asia Pacific

8. Company Profiles
8.1. Acura Pharmaceuticals Inc
8.2. Allergan Plc
8.3. Biodelivery Sciences International Inc
8.4. Cipher Pharmaceuticals Inc
8.5. Collegium Pharmaceutical Inc
8.6. Daiichi Sankyo Inc
8.7. Egalet Corp
8.8. Hikma Pharmaceuticals Plc
8.9. Indivior Inc
8.10. Janssen Pharmaceuticals Inc
8.11. Johnson & Johnson
8.12. Lannett Co. Inc
8.13. Lupin Ltd
8.14. Mylan Nv
8.15. Pfizer Inc
8.16. Purdue Pharma Lp
8.17. Sanofi-Aventis S.A
8.18. Sun Pharmaceutical Industries Limited (Sun Pharma)
8.19. Teva Pharmaceutical Industries Ltd



List of Figures


Figure 1: Key Investment Insights
Figure 2: Porter’S Five Force Analysis
Figure 3: Opportunity Matrix
Figure 4: Vendor Landscape
Figure 5: Asia Pacific Opioids Drugs Market, Growth Potential, By Product, In 2019
Figure 6: Asia Pacific Opioids Drugs Market, By Buprenorphine, 2019-2028 (In $ Million)
Figure 7: Asia Pacific Opioids Drugs Market, By Fentanyl, 2019-2028 (In $ Million)
Figure 8: Asia Pacific Opioids Drugs Market, By Hydrocodone, 2019-2028 (In $ Million)
Figure 9: Asia Pacific Opioids Drugs Market, By Morphine, 2019-2028 (In $ Million)
Figure 10: Asia Pacific Opioids Drugs Market, By Oxycodone, 2019-2028 (In $ Million)
Figure 11: Asia Pacific Opioids Drugs Market, By Tramadol, 2019-2028 (In $ Million)
Figure 12: Asia Pacific Opioids Drugs Market, By Other Products, 2019-2028 (In $ Million)
Figure 13: Asia Pacific Opioids Drugs Market, Growth Potential, By Application, In 2019
Figure 14: Asia Pacific Opioids Drugs Market, By Pain Relief, 2019-2028 (In $ Million)
Figure 15: Asia Pacific Pain Relief Market, By Cancer Pain, 2019-2028 (In $ Million)
Figure 16: Asia Pacific Pain Relief Market, By Postoperative Pain Management, 2019-2028 (In $ Million)
Figure 17: Asia Pacific Pain Relief Market, By Low Back Pain, 2019-2028 (In $ Million)
Figure 18: Asia Pacific Pain Relief Market, By Orthopedic, 2019-2028 (In $ Million)
Figure 19: Asia Pacific Pain Relief Market, By Fibromyalgia, 2019-2028 (In $ Million)
Figure 20: Asia Pacific Pain Relief Market, By Neuropathic, 2019-2028 (In $ Million)
Figure 21: Asia Pacific Opioids Drugs Market, By Anesthesia, 2019-2028 (In $ Million)
Figure 22: Asia Pacific Opioids Drugs Market, By Cough Suppression, 2019-2028 (In $ Million)
Figure 23: Asia Pacific Opioids Drugs Market, By Diarrhea Suppression, 2019-2028 (In $ Million)
Figure 24: Asia Pacific Opioids Drugs Market, By Deaddiction, 2019-2028 (In $ Million)
Figure 25: Asia Pacific Opioids Drugs Market, Country Outlook, 2018 & 2028 (In %)
Figure 26: China Opioids Drugs Market, 2020-2028 (In $ Million)
Figure 27: Japan Opioids Drugs Market, 2020-2028 (In $ Million)
Figure 28: India Opioids Drugs Market, 2020-2028 (In $ Million)
Figure 29: South Korea Opioids Drugs Market, 2020-2028 (In $ Million)
Figure 30: Indonesia Opioid Drugs Market, 2020-2028 (In $ Million)
Figure 31: Thailand Opioid Drugs Market, 2020-2028 (In $ Million)
Figure 32: Vietnam Opioid Drugs Market, 2020-2028 (In $ Million)
Figure 33: Australia & New Zealand Opioid Drugs Market, 2020-2028 (In $ Million)


List of Tables


TABLE 1: MARKET SNAPSHOT - OPIOIDS DRUGS
TABLE 2: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 3: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 4: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 5: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 6: ASIA PACIFIC PAIN RELIEF MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION):
TABLE 7: ASIA PACIFIC PAIN RELIEF MARKET, BY TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION):
TABLE8: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 9: ASIA PACIFIC OPIOIDS DRUGS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)